Opti-EPA™ Enteric-Coated softgels supply significant amounts of essential omega-3 fatty acids, derived from marine lipid concentrate. Processed by molecular distillation, each softgel provides 330 mg of EPA and 170 mg of DHA. Opti-EPA™ is enteric-coated, significantly reducing the -fishy”” taste sometimes associated with marine lipid supplements.
Typical diets in developed countries deliver large amounts of saturated and polyunsaturated omega-6 acids, while providing low levels of omega-3 fatty acids. A healthy balance of dietary omega-6 and omega-3 fatty acids appears necessary for the maintenance of good health. Unlike dietary omega-6 fatty acids, EPA and DHA serve as precursors for the anti-inflammatory prostaglandins E1 and E3, and decrease the formation of pro-inflammatory cytokines.
In addition to decreasing arthritic symptoms, the ability of fish oil to support the body’s normal inflammatory processes plays an important role in cardiovascular health. Omega-3 fatty acids also promote cardiovascular function by lowering LDL and triglycerides, inhibiting excessive platelet aggregation, reducing fibrinogen levels and supporting healthy heart rhythms.
Brain function is also positively affected by omega-3 supplementation. As the most abundant fatty acid in the brain, adequate amounts of DHA are needed throughout adulthood for ongoing optimal function. Omega-3 fatty acids are also essential to the normal brain development of the newborn, especially during the last three months of pregnancy when brain development increases threefold.
All Douglas Laboratories products are GMO-free. All allergens are disclosed on the label in accordance with Health Canada labeling guidelines for the 11 major allergens: eggs, milk, mustard, peanuts, seafood, sesame, soy, sulphites, tree nuts, wheat and gluten. Comprehensive allergen procedures are in place to prevent ingredient cross-contamination during manufacturing and storage.